11/27
02:48 pm
hbio
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
01:59 pm
hbio
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
01:27 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
Medium
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
11/17
01:27 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
Medium
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
11/9
08:55 am
hbio
Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest Report [Yahoo! Finance]
High
Report
Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest Report [Yahoo! Finance]
11/9
01:13 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was downgraded by analysts at
Wall Stre
High
Report
Harvard Bioscience (NASDAQ:HBIO) was downgraded by analysts at
Wall Stre
11/7
07:07 pm
hbio
Is It Time To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? [Yahoo! Finance]
High
Report
Is It Time To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? [Yahoo! Finance]
11/7
02:18 am
hbio
Harvard Bioscience targets $22.5M–$24.5M Q4 revenue as backlog reaches two-year high, expanding product rollouts and distribution [Seeking Alpha]
Medium
Report
Harvard Bioscience targets $22.5M–$24.5M Q4 revenue as backlog reaches two-year high, expanding product rollouts and distribution [Seeking Alpha]
11/6
07:00 am
hbio
Harvard Bioscience Announces Third Quarter 2025 Financial Results
High
Report
Harvard Bioscience Announces Third Quarter 2025 Financial Results
10/30
08:00 am
hbio
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Medium
Report
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
9/16
07:00 am
hbio
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
Low
Report
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
9/10
08:25 am
hbio
Harvard Bioscience (NASDAQ:HBIO) had its price target lowered by analysts at Benchmark Co. from $3.00 to $2.00. They now have a "speculative buy" rating on the stock.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) had its price target lowered by analysts at Benchmark Co. from $3.00 to $2.00. They now have a "speculative buy" rating on the stock.
9/9
07:37 am
hbio
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors [Yahoo! Finance]
Medium
Report
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors [Yahoo! Finance]
9/9
07:00 am
hbio
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
Medium
Report
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors